Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction

Current Biology

Volumn 8, Issue 2, 1998, Pages 113-116

  Wajant, Harald ^a   Johannes, Franz Josef ^a   Haas, Elvira ^a   Siemienski, Katrin ^a   Schwenzer, Ralph ^a   Schubert, Gisela ^a   Weiss, Tilo ^a   Grell, Matthias ^a   Scheurich, Peter ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032518446     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(98)70042-9     Document Type: Article

References (27)

1. Itoh N, Nagata S: A novel protein domain required for apoptosis: mutational analysis of human Fas antigen. J Biol Chem 1993, 268:10932-10937.
2. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV: A novel domain within the 55 kD TNF receptor signals cell death. Cell 1993, 74:845-853.
3. Chinnaiyan AM, O'Rourke K, Yu G-L, Lyons RH, Garg M, Duan DR, et al.: Signal transduction by DR-3, a death domain-containing receptor related to TNFR1 and CD95. Science 1996, 274:990-992.
4. Kitson J, Raven T, Jiang Y-P, Goeddel DV, Giles KM, Pun K-T, et al.: A death-domain-containing receptor that mediates apoptosis. Nature 1996, 384:372-375.
5. Marsters SA, Sheridan JP, Donahue J, Pitti RM, Gray CL, Goddard AD et al.: Apo-3, a new member of the tumor necrosis factor family, contains a death domain and activates apoptosis and NF-κB. Curr Biol 1996, 6:1669-1676.
6. Bodmer J-L, Burns B, Schneider P, Hofmann K, Steiner V, Thome M et al.: TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/ CD95). Immunity 1997, 6:79-88.
7. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, et al.: The receptor for the cytotoxic ligand TRAIL. Science 1997, 276:111-113.
8. Screaton GR, Xu X-N, Olsen AL, Cowper AE, Tan R, McMichael A, et al.: LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci USA 1997, 94:4615-4619.
9. Pan G, Ni J, Wej Y-F, Yu G-L, Gentz R, Dixit VM: An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997, 277:815-817.
10. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, et al.: Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997, 277:818-820.
11. Screaton GR, Mongkolsapaya J, Xu X-N, Cowper AE, McMichael AJ, Bell JI: TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL. Curr Biol 1997, 7:693-696.
12. Hsu H, Xiong J, Goeddel DV: The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 1995, 81:495-504.
13. Hsu H, Shu H-B, Pan M-G, Goeddel DV: TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transcription pathways. Cell 1996, 84:299-308.
14. Chinnayan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995, 81:505-512.
15. Boldin MP, Varfolomeev EE, Pnancer C, Mett IL, Camonis JH, Wallach D: A novel protein that interacts with the death domain of Fas/Apo1 contains a sequence motif related to the death domain. J Biol Chem 1995, 270:7795-7798.
16. Nagata S: Apoptosis by death factor. Cell 1997, 88:355-365.
17. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, et al.: Cytotoxicity-dependent Apo-1(Fas/ CD95)-associated proteins from a death-inducing signaling complex (DISC) with the receptor. EMBO J 1995, 14:5579-5588.
18. Boldin MP, Goncharov TM, Goltsev YV, Wallach D: Involvement of MACH, a novel MORT1/ FADD-interacting protease in Fas/ Apo-1-and TNF receptor-induced cell death. Cell 1996, 85:803-815.
19. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, et al.: FLICE, a novel FADD-homologous ICE/ CED-3-like protease, is recruited to the CD95 (Fas/ APO-1) death-inducing signaling complex. Cell 1996, 85:817-827.
20. Chinnaiyan AM, Tepper CG, Seldin MF, ORourke K, Kischkel FC, Hellbardt S, et al.: FADD/ MORT1 is a common mediator of CD95 (Fas/ APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 1996, 271:4961-4965.
21. Marsters SA, Pitti RM, Donahue CJ, Ruppert S, Bauer KD, Ashkenazi A: Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by crmA. Curr Biol 1996, 6:750-752.
22. Duan H, Dixit VM: RAIDD is a new 'death' adaptor molecule. Nature 1997, 385:86-89.
23. Ahmad M, Srinivasula SM, Wang L, Talanian RV, Litwack G, Fernandes-Alnemri T, et al.: CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/ tumor necrosis factor receptor-interacting protein RIP. Cancer Res 1997, 57:615-619.
24. Malinin NL, Boldin MP, Kovalenko AV, Wallach D: MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 1997, 385:540-544.
25. Yang X, Khosravi-Far R, Chang HY, Baltimore D: Daxx, a novel Fasbinding protein that activates JNK and apoptosis. Cell 1997, 89:1067-1076.
26. Weiss T, Grell M, Hessabi B, Bourteele S, Müller G, Scheurich P, et al.: Enhancement of TNFR60-mediated cytotoxicity by TNFR80- requirement of the TRAF2 binding site. J Immunol 1997, 158:2398-2404.
27. Berberich I, Shu G, Siebelt F, Woodgett JR, Kyriakis JM, Clark EA: Cross-linking CD40 on B cells preferentially induces stressactivated protein kinases rather than mitogen-activated protein kinases. EMBO J 1996, 15:92-101.